Poitiers, France

Martine Mondon

This inventor holds 4 USPTO granted patents. Top assignees: Behringwerke Aktiengesellschaft, Laboratoires Hoechst S/a, Laboratoires Hoechst. Active years: 1988-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martine Mondon. Retrieved from https://idiyas.com/inventor/martine-mondon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1988-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Martine Mondon: Innovator in Flavone Derivatives

Introduction

Martine Mondon is a notable inventor based in Poitiers, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel flavone and isoflavone derivatives. With a total of 4 patents to her name, Mondon's work has implications for treating rheumatic diseases.

Latest Patents

One of her latest patents is focused on a preparation method for 7-carboxy-flavone derivatives and their therapeutic use. This invention involves novel flavone and isoflavone derivatives characterized by specific chemical formulae. The compounds are designed to be useful in the treatment of rheumatic diseases, showcasing Mondon's commitment to advancing medical science.

Career Highlights

Throughout her career, Martine Mondon has worked with prominent companies such as Behringwerke Aktiengesellschaft and Laboratoires Hoechst S.A. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations.

Collaborations

Mondon has collaborated with esteemed colleagues, including Jean-Pierre Gesson and Jean-Claude Jacquesy. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Martine Mondon's innovative work in the field of flavone derivatives highlights her significant contributions to medicinal chemistry. Her patents reflect her dedication to improving therapeutic options for patients with rheumatic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…